Cardiac Allograft Vasculopathy Inhibition with Alirocumab: The CAVIAR Trial.

Journal:

Circulation

Published:

2025-11-11

DOI:

10.1161/circulationaha.125.077603

Affiliations:

6

Authors:

16

Go to article

Institutions	Authors	Share
Stanford Medicine, United States of America (USA)	11.500000 11.500000	0.72
Kaiser Permanente Santa Clara Medical Center and Medical Offices, United States of America (USA)	2.000000	0.13
Stanford University, United States of America (USA)	1.000000	0.06
St. Antonius Hospital, Netherlands	1.000000	0.06
VA Palo Alto Healthcare System (VAPAHCS), United States of America (USA)	0.500000	0.03

Interested in Cardiovascular Medicine and Haematology?